GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Greenrise Global Brands Inc (XCNQ:XCX) » Definitions » Debt-to-EBITDA

Greenrise Global Brands (XCNQ:XCX) Debt-to-EBITDA : 182.54 (As of Jun. 2024)


View and export this data going back to 2011. Start your Free Trial

What is Greenrise Global Brands Debt-to-EBITDA?

Debt-to-EBITDA measures a company's ability to pay off its debt.

Greenrise Global Brands's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2024 was C$4.38 Mil. Greenrise Global Brands's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2024 was C$0.00 Mil. Greenrise Global Brands's annualized EBITDA for the quarter that ended in Jun. 2024 was C$0.02 Mil. Greenrise Global Brands's annualized Debt-to-EBITDA for the quarter that ended in Jun. 2024 was 182.54.

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

The historical rank and industry rank for Greenrise Global Brands's Debt-to-EBITDA or its related term are showing as below:

XCNQ:XCX' s Debt-to-EBITDA Range Over the Past 10 Years
Min: -23.01   Med: -0.62   Max: 81.13
Current: 81.13

During the past 13 years, the highest Debt-to-EBITDA Ratio of Greenrise Global Brands was 81.13. The lowest was -23.01. And the median was -0.62.

XCNQ:XCX's Debt-to-EBITDA is ranked worse than
99.54% of 654 companies
in the Drug Manufacturers industry
Industry Median: 1.81 vs XCNQ:XCX: 81.13

Greenrise Global Brands Debt-to-EBITDA Historical Data

The historical data trend for Greenrise Global Brands's Debt-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Greenrise Global Brands Debt-to-EBITDA Chart

Greenrise Global Brands Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Debt-to-EBITDA
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.13 -0.53 -0.72 -2.53 -23.01

Greenrise Global Brands Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
Debt-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -4.95 -15.44 11.25 50.02 182.54

Competitive Comparison of Greenrise Global Brands's Debt-to-EBITDA

For the Drug Manufacturers - Specialty & Generic subindustry, Greenrise Global Brands's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Greenrise Global Brands's Debt-to-EBITDA Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Greenrise Global Brands's Debt-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Greenrise Global Brands's Debt-to-EBITDA falls into.



Greenrise Global Brands Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

Greenrise Global Brands's Debt-to-EBITDA for the fiscal year that ended in Dec. 2023 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(0.263 + 3.833) / -0.178
=-23.01

Greenrise Global Brands's annualized Debt-to-EBITDA for the quarter that ended in Jun. 2024 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(4.381 + 0) / 0.024
=182.54

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is four times the quarterly (Jun. 2024) EBITDA data.


Greenrise Global Brands  (XCNQ:XCX) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.


Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.


Greenrise Global Brands Debt-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Greenrise Global Brands's Debt-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Greenrise Global Brands Business Description

Traded in Other Exchanges
Address
224 5th Avenue West, Vancouver, BC, CAN, V5Y 1J4
Greenrise Global Brands Inc helps Germans benefit from the well-being benefits of cannabis through its CBD wellness and medical cannabis businesses. The Company has one reportable business segment, being the pharmaceutical supply of medical cannabis products to German pharmacies.

Greenrise Global Brands Headlines

No Headlines